Cargando…

Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment

Background: Large core is associated with poor outcome in acute ischemic stroke (AIS) patients. It is unclear whether endovascular treatment (EVT) could bring benefits to patients with core volume ≥70 ml before treatment. We aimed to compare the impact of EVT with intravenous thrombolysis (IVT) on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhicai, Zhang, Ruiting, Zhou, Ying, Gong, Xiaoxian, Zhang, Meixia, Shi, Feina, Yu, Xinfeng, Lou, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230959/
https://www.ncbi.nlm.nih.gov/pubmed/30455665
http://dx.doi.org/10.3389/fneur.2018.00933
_version_ 1783370147436691456
author Chen, Zhicai
Zhang, Ruiting
Zhou, Ying
Gong, Xiaoxian
Zhang, Meixia
Shi, Feina
Yu, Xinfeng
Lou, Min
author_facet Chen, Zhicai
Zhang, Ruiting
Zhou, Ying
Gong, Xiaoxian
Zhang, Meixia
Shi, Feina
Yu, Xinfeng
Lou, Min
author_sort Chen, Zhicai
collection PubMed
description Background: Large core is associated with poor outcome in acute ischemic stroke (AIS) patients. It is unclear whether endovascular treatment (EVT) could bring benefits to patients with core volume ≥70 ml before treatment. We aimed to compare the impact of EVT with intravenous thrombolysis (IVT) on the outcome in patients with core volume ≥70 ml. Methods: We included consecutive anterior circulation AIS patients who underwent MR or CT perfusion within 6 h post stroke onset, which revealed a core ≥70 ml before reperfusion therapy. Good outcome was defined by modified Rankin Scale of 0 to 2 at 90-day. Reperfusion was defined as a reduction in hypoperfusion volume of ≥70% between baseline and 24 h. Results: One hundred four patients were included. Among them, 76 received IVT only, and 28 received EVT. After adjusting for age, NIHSS score, baseline core volume and onset to imaging time, patients in EVT group were more likely to achieve good outcome compared to IVT patients (OR, 3.875; 95% Cl 1.068–14.055, p = 0.039). More patients in EVT group achieved recanalization (84.0 vs. 58.5%, p = 0.027) and reperfusion (66.7 vs. 33.3%, p = 0.010) than in IVT group. Reperfusion also independently predicted good outcome (OR, 7.718; 95% Cl 1.713-34.772, p = 0.008). All patients with good outcome achieved recanalization at 24 h. Conclusions: Our data indicated that patients with core volume ≥70 ml might still benefit from EVT, which was related to its high reperfusion rate.
format Online
Article
Text
id pubmed-6230959
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62309592018-11-19 Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment Chen, Zhicai Zhang, Ruiting Zhou, Ying Gong, Xiaoxian Zhang, Meixia Shi, Feina Yu, Xinfeng Lou, Min Front Neurol Neurology Background: Large core is associated with poor outcome in acute ischemic stroke (AIS) patients. It is unclear whether endovascular treatment (EVT) could bring benefits to patients with core volume ≥70 ml before treatment. We aimed to compare the impact of EVT with intravenous thrombolysis (IVT) on the outcome in patients with core volume ≥70 ml. Methods: We included consecutive anterior circulation AIS patients who underwent MR or CT perfusion within 6 h post stroke onset, which revealed a core ≥70 ml before reperfusion therapy. Good outcome was defined by modified Rankin Scale of 0 to 2 at 90-day. Reperfusion was defined as a reduction in hypoperfusion volume of ≥70% between baseline and 24 h. Results: One hundred four patients were included. Among them, 76 received IVT only, and 28 received EVT. After adjusting for age, NIHSS score, baseline core volume and onset to imaging time, patients in EVT group were more likely to achieve good outcome compared to IVT patients (OR, 3.875; 95% Cl 1.068–14.055, p = 0.039). More patients in EVT group achieved recanalization (84.0 vs. 58.5%, p = 0.027) and reperfusion (66.7 vs. 33.3%, p = 0.010) than in IVT group. Reperfusion also independently predicted good outcome (OR, 7.718; 95% Cl 1.713-34.772, p = 0.008). All patients with good outcome achieved recanalization at 24 h. Conclusions: Our data indicated that patients with core volume ≥70 ml might still benefit from EVT, which was related to its high reperfusion rate. Frontiers Media S.A. 2018-11-05 /pmc/articles/PMC6230959/ /pubmed/30455665 http://dx.doi.org/10.3389/fneur.2018.00933 Text en Copyright © 2018 Chen, Zhang, Zhou, Gong, Zhang, Shi, Yu and Lou. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Chen, Zhicai
Zhang, Ruiting
Zhou, Ying
Gong, Xiaoxian
Zhang, Meixia
Shi, Feina
Yu, Xinfeng
Lou, Min
Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment
title Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment
title_full Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment
title_fullStr Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment
title_full_unstemmed Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment
title_short Patients With Ischemic Core ≥70 ml Within 6 h of Symptom Onset May Still Benefit From Endovascular Treatment
title_sort patients with ischemic core ≥70 ml within 6 h of symptom onset may still benefit from endovascular treatment
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230959/
https://www.ncbi.nlm.nih.gov/pubmed/30455665
http://dx.doi.org/10.3389/fneur.2018.00933
work_keys_str_mv AT chenzhicai patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment
AT zhangruiting patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment
AT zhouying patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment
AT gongxiaoxian patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment
AT zhangmeixia patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment
AT shifeina patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment
AT yuxinfeng patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment
AT loumin patientswithischemiccore70mlwithin6hofsymptomonsetmaystillbenefitfromendovasculartreatment